List of SBIR/STTR awards granted to Halomine
HalomineName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Halomine in August, 2020 for $600,000.0 USD from the U.S. Department of Agriculture. | SBIR | 2020-07058 | Phase II | 600,000 | August 19, 2020 | |||||||
A SBIR Phase I contract was awarded to Halomine in August, 2020 for $250,255.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI155114-01 | Phase I | 250,255 | August 5, 2020 | |||||||
A SBIR Phase I contract was awarded to Halomine in May, 2020 for $225,000.0 USD from the National Science Foundation. | SBIR | 2014378 | Phase I | 225,000 | May 15, 2020 | |||||||
A SBIR Phase I contract was awarded to Halomine in June, 2020 for $256,000.0 USD from the National Science Foundation. | SBIR | 2028187 | Phase I | 256,000 | June 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Halomine in February, 2022 for $174,995.0 USD from the U.S. Department of Agriculture. | SBIR | 2022-00776 | Phase I | 174,995 | February 25, 2022 | |||||||
A SBIR Phase II contract was awarded to Halomine in September, 2021 for $1,000,000.0 USD from the National Science Foundation. | SBIR | 2126610 | Phase II | 1,000,000 | September 15, 2021 | |||||||
A SBIR Phase I contract was awarded to Halomine in July, 2020 for $99,890.0 USD from the U.S. Department of Defense and United States Army. | SBIR | W81XWH-21-P-0035 | Phase I | 99,890 | July 7, 2020 | |||||||
A SBIR Phase II contract was awarded to Halomine in December, 2022 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI155114-02 | Phase II | 1,000,000 | December 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Halomine in June, 2023 for $325,001.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK136450-01 | Phase I | 325,001 | June 5, 2023 |
